Impaired oxidative phosphorylation in skeletal muscle of intrauterine growth-retarded rats

American Journal of Physiology - Endocrinology and Metabolism

Volumn 285, Issue 1 48-1, 2003, Pages

  Selak, Mary A ^a   Storey, Bayard T ^a   Peterside, Iyalla ^a   Simmons, Rebecca A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Diabetes; Intrauterine growth retardation; Pyruvate dehydrogenase

Indexed keywords

2 OXOGLUTARIC ACID; ADENOSINE TRIPHOSPHATE; DEOXYGLUCOSE; GLUTAMIC ACID; GLYCOGEN; INSULIN; PYRUVATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE KINASE 4; PYRUVIC ACID; SUCCINIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENERGY; ENZYME ACTIVITY; FEMALE; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HYPERGLYCEMIA; INSULIN RESISTANCE; INTRAUTERINE GROWTH RETARDATION; MUSCLE MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATION; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PLACENTA INSUFFICIENCY; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; SYNTHESIS;

EID: 0038001567     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00322.2002     Document Type: Article

References (55)

1. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, and Clark PM. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidemia (syndrome X): relation to reduced fetal growth. Diabetologia 36: 62-67, 1993.
2. Barker DJP and Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet I: 1077-1081, 1986.
3. Baron AD, Brechtel G, Wallace P, and Edelman SV. Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol Endocrinol Metab 255: E769-E774, 1988.
4. Bessman SP and Geiger PJ. Transport of energy in muscle: the phosphorylcreatine shuttle. Science 211: 448-452, 1981.
5. Birch-Machin MA, Briggs HL, Saborido AA, Bindoff LA, and Turnbull DM. An evaluation of the measurement of the activities of complexes I-IV in the respiratory chain of human skeletal muscle mitochondria. Biochem Med Metab Biol 51: 35-42, 1994.
6. Bloxam DL. Nutritional aspects of amino acid metabolism. 3. The effects of diabetes on blood and liver amino acid concentration in the rat. Br J Nutr 27: 249-259, 1972.
7. Bonadonna RC, Del Prato S, and Bonora E. Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes 45: 915-925, 1996.
8. Bowker-Kinley MM, Davis WI, Wu P, Harris RA, and Popov KM. Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex. Biochem J 329: 191-196, 1998.
9. Chance B and Williams GR. The respiratory chain and oxidative phosphorylation. Adv Enzymol Relat Areas Mol Biol 17: 65-134, 1956.
10. Chappell BB and Perry SV. Biochemical and osmotic properties of skeletal muscle mitochondria. Nature 173: 1084-1095, 1954.
11. Cline GW, Petersen KF, Krssak M, Shen J, Hundal RS, Trajanoski Z, Inzucchi S, Dresner A, Rothman DL, and Shulman GI. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med 341: 240-246, 1999.
12. Denton RM and McCormack JG. Calcium transport by mammalian mitochondria and its role in hormone action. Am J Physiol Endocrinol Metab 249: E543-E554, 1985.
13. Dohm GL, Tapscott EB, and Pories WJ. An in vitro human muscle preparation suitable for metabolic studies: decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. J Clin Invest 82: 486-494, 1988.
14. Ernster L and Nordenbrand K. Skeletal muscle mitochondria. Methods Enzymol 10: 86-96, 1967.
15. Estabrook RW. Mitochondrial respiratory control and the polarographic measurement of ADP:O ratios. Methods Enzymol 10: 41-47, 1967.
16. Felig P, Marliss E, and Cahill GF Jr. Plasma amino acid levels and insulin secretion in obesity. N Engl J Med 268: 811-816, 1969.
17. Gebhart SS, Shoffner JM, Koontz D, Kaufman A, and Wallace D. Insulin resistance associated with maternally inherited diabetes and deafness. Metabolism 45: 526-531, 1996.
18. Geddes R. Glycogen: a metabolic viewpoint. Biosci Rep 6: 415-428, 1986.
19. Godi R, Bowker-Kinley MM, Kedishvili NY, Zhao Y, and Popov KM. Diversity of the pyruvate dehydrogenase kinase gene family in humans. J Biol Chem 270: 28989-28994, 1995.
20. Hales CN, Barker DJP, Clark PMS, Cox LJ, Fall C, and Osmond C. Fetal and infant growth and impaired glucose tolerance at age 64 years. Br Med J 303: 1019-1022, 1991.
21. Heytler PG. Uncouplers of oxidative phosphorylation. Pharmacol Ther 10: 461-472, 1980.
22. Hresko RC, Heimberg H, Chi MMY, and Mueckler M. Glucosamine-induced insulin resistance in 3T3-L1 adipocytes is caused by depletion of intracellular ATP. J Biol Chem 273: 20658-20668, 1998.
23. Huang B, Wu P, Bowker MM, and Harris RA. Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator-activated receptor-alpha ligands, glucocorticoids, and insulin. Diabetes 51: 276-283, 2002.
24. Kang J, Heart E, and Sung CK. Effects of cellular ATP depletion on glucose transport and insulin signaling in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 280: E428-E435, 2001.
25. Keppler D and Decker K. Glycogen. Determination with amyloglucosidase. In: Methods of Enzymatic Analysis (2nd ed.), edited by Bergmeyer HU. New York: Academic, 1974, p. 1127-1131.
26. Krebs M, Krssak M, Bernroider E, Anderwald C, Brehm A, Meyerspeer M, Nowotny P, Roth E, Waldhausl W, and Roden M. Mechanism of amino acid-induced skeletal muscle insulin resistance in humans. Diabetes 51: 599-605, 2002.
27. Lane RH, Chandorkar AK, Flozak AF, and Simmons RA. Intrauterine growth retardation alters mitochondrial gene expression and function in fetal and juvenile rat skeletal muscle. Pediatr Res 43: 563-570, 1998.
28. Lee CP, Martens ME, and Tsang SH. Small-scale preparation of skeletal muscle mitochondria and its application in the study of human disease. Methods Toxicol 2: 70-83, 1993.
29. Lillioja S, Mott DM, Zawadzki JK, Young AA, Abbott WG, and Bogardus C. Glucose storage is a major determinant of in vivo "insulin resistance" in subjects with normal glucose tolerance. J Clin Endocrinol Metab 62: 922-927, 1986.
30. Livnat TM, Chen-Zion M, and Beitner R. Uncoupling of mitochondrial oxidative phosphorylation abolishes the stimulatory action of insulin on the binding of glycolytic enzymes to muscle cytoskeleton. Int J Biochem 25: 993-997, 1993.
31. Majer M, Popov KM, Harris RA, Bogardus C, and Prochazka M. Insulin downregulates pyruvate dehydrogenase kinase (PDK) mRNA: potential mechanism contributing to increased lipid oxidation in insulin-resistant subjects. Mol Genet Metab 65: 181-186, 1998.
32. Makinen MW and Lee CP. Biochemical studies of skeletal muscle mitochondria. I. Microanalysis of cytochrome content, oxidative and phosphorylative activities of mammalian skeletal muscle mitochondria. Arch Biochem Biophys 126: 75-82, 1968.
33. Martens ME, Peterson PL, and Lee CP. In vitro effects of glucocorticoids on mitochondrial energy metabolism. Biochim Biophys Acta 1058: 152-160, 1991.
34. Ogata ES, Bussey M, and Finley S. Altered gas exchange, limited glucose, branched chain amino acids, and hypoinsulinism retard fetal growth in the rat. Metabolism 35: 950-977, 1986.
35. Orfali KA, Fryer LG, Holness MJ, and Sugden MC. Longterm regulation of pyruvate dehydrogenase kinase by high-fat feeding. Experiments in vivo and in cultured cardiomyocytes. FEBS Lett 336: 501-505, 1993.
36. Park KS, Ciaraldi TP, Carter L, Mudaliar S, Nikoulina SE, Webster NJG, and Henry RR. Induction of insulin resistance in human skeletal muscle cells by downregulation of glycogen synthesis protein expression. Metabolism 49: 962-968, 2000.
37. Ravelli G, Stein ZA, and Susser MW. Obesity in young men after famine exposure in utero and early infancy. N Engl J Med 295: 349-354, 1995.
38. Rich-Edwards JW, Colditz GA, Stampfer MJ, Willett WC, Gillman MW, Hennekens CH, Speizer FE, and Manson JE. Birthweight and the risk for type 2 diabetes mellitus in adult women. Ann Intern Med 130: 278-284, 1999.
39. Robinson JB, Brent LG, Sumegi B, and Srere PA. An enzymatic approach to the study of the Krebs tricarboxylic acid cycle. In: Mitochondria: A Practical Approach, edited by Darley-Usmar VM, Rickwood D, and Wilson MT. Oxford: IRL, 1987.
40. Rothman DL, Magnusson I, Cline G, Gerard D, Kahn C, Shulman RG, and Shulman GI. Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 92: 983-987, 1995.
41. Rothman DL, Shulman RG, and Shulman GI. 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate: evidence for reduced insulin-dependent muscle glucose transport on phosphorylation activity in non-insulin-dependent diabetes mellitus. J Clin Invest 89: 1069-1075, 1992.
42. Scharff R and Wool IG. Effect of diabetes on the concentration of amino acids in plasma and heart muscle of rats. Biochem J 99: 173-178, 1966.
43. Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, and Shulman RG. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin- dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322: 223-238, 1990.
44. Simmons RA, Gounis AS, Bangalore SA, and Ogata ES. Intrauterine growth retardation: fetal glucose transport is diminished in lung but spared in brain. Pediatr Res 31: 59-63, 1991.
45. Simmons RA, Templeton LJ, and Gertz SA. Intrauterine growth retardation leads to the development of type 2 diabetes in the rat. Diabetes 50: 2279-2286, 2001.
46. Simoneau J-A and Kelley DE. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol 83: 166-171, 1997.
47. Slater EC. Application of inhibitors and uncouplers for a study of oxidative phosphorylation. Methods Enzymol 10: 48-57, 1967.
48. Unterman T, Lascon R, Gotway M, Oehler D, Gounis A, Simmons RA, and Ogata ES. Circulating levels of insulin-like growth factor binding protein-1 (IGFBP-1) and hepatic mRNA are increased in the small for gestational age fetal rat. Endocrinology 127: 2035-2037, 1990.
49. Valdez R, Athens MA, Thompson GH, Bradshaw BS, and Stern MP. Birthweight and adult health outcomes in a biethnic population in the USA. Diabetologia 37: 624-631, 1994.
50. LEU(UUR) gene mutation. Diabetes 45: 478-487, 1996.
51. Wahren J, Felig P, Cerasi E, and Luft R. Splanchnic and peripheral glucose and amino acid metabolism in diabetes mellitus. J Clin Invest 51: 1870-1878, 1972.
52. Williamson JR and Cooper RH. Regulation of the citric acid cycle in mammalian systems. FEBS Lett 117, Suppl: K73-K85, 1980.
53. Wu P, Inskeep K, Bowker-Kinley MM, Popov KM, and Harris RA. Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes. Diabetes 48: 1593-1599, 1999.
54. Young DA, Uhl JJ, Cartee GD, and Holloszy JO. Activation of glucose transport in muscle by prolonged exposure to insulin. J Biol Chem 261: 16049-16053, 1986.
55. Zierath JR, He L, Guma A, Odegoard Wahlstrom E, Klip A, and Wallberg-Henriksson H. Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM. Diabetologia 39: 1180-1189, 1996.